“Since the time we moved to the IZB, our headcount grew steadily from 6 to 60 employees. The IZB supported us continuously and we look forward to being part of the IZB in future.”

Michael Scholl, CEO & Dr. Andreas Seidl, COO
LEUKOCARE AG

“The IZB offers biotechnology start-ups a great home. The infrastructure and support provided by the IZB help to build up the company, and the start-up environment offers extensive opportunities for exchange and cooperation.”

Dr. Rüdiger Jankowsky, AATec Medical GmbH

“We look forward to you expanding the leading biotech cluster in Europe and its strong network of unique companies, doubling the area by 2025 and quadrupling it by 2030.”

Dr. Kai Lamottke, Managing Director Bicoll GmbH

“We aim to discover and develop the next generation of small molecule immunomodulatory compounds to improve the standard of care. The expertise of our colleagues in Martinsried is a key element to achieve this.”

Dr. Sierk Poetting, CFO & COO BioNTech SE

“We’re a Cultivated Company. Creating consumer products where science meets soul.”

Viktor Sartakov-Korzhov, CEO

“We’re a Cultivated Company. Creating consumer products where science meets soul.“

Viktor Sartakov-Korzhov, CEO

“The Innovation and Start-up Center Biotechnology (IZB) is a vibrant hub for biotech innovation, providing state-of-the-art facilities and fostering collaboration among over 40 companies. It serves as a critical platform for start-ups like ours, enabling us to tackle pressing medical challenges and drive advancements in biomarker discovery.”

Dr. Philipp Geyer, Dr. Sebastian Virreira Winter, Dr. Sophia Viellechner

The start-ups at the IZB

The Innovation and Start-up Centers Biotechnology (IZB) in Martinsried and Weihenstephan offer start-ups a creative environment in cutting-edge research at Martinsried Campus and Weihenstephan Campus. Entrepreneurs benefit from high-quality building infrastructure, flexibly designed office space and furnished laboratory units (S1 laboratories) at fair prices.

Successful companies that have emerged from the IZB include Medigene AG, Morphosys AG, Micromet GmbH (today Amgen Inc.), Octopharma GmbH, Corimmun GmbH (today Janssen-Cilag), Proteros GmbH, Coriolis Pharma Research GmbH, Rigontec GmbH (today MSD) and Exosome Diagnostics (today Bio-Techne) as well as the 4SC AG.

The start-ups at the IZB

Start-ups currently based

Former start-ups

IZB on YouTube

IZB on linkedIn